Abacus Life (ABL) Stock Price, News & Analysis

Company Overview

Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

Key Stats

• Today's Range: $5.20 to $5.37
• 50-Day Range: $4.64 to $8.96
• 52-Week Range: $4.60 to $11.86
• Volume: 726,876 shs
• Average Volume: 361,541 shs
• Market Capitalization: $516.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $13.75
• Consensus Rating: Buy

Abacus Life Stock Analysis - MarketRank™

Abacus Life scored higher than 59% of companies evaluated by MarketBeat, and ranked 541st out of 936 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Buy

Consensus Rating

Abacus Life has received a consensus rating of Buy. The company's average rating score is 3.14, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Abacus Life has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 20.97%

Earnings Growth

Earnings for Abacus Life are expected to grow by 20.97% in the coming year, from $0.62 to $0.75 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Abacus Life is -23.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Abacus Life is -23.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Abacus Life has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.78% of the float of Abacus Life has been sold short.

Short Interest Ratio / Days to Cover

Abacus Life has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Abacus Life has recently increased by 47.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Abacus Life does not currently pay a dividend.

Dividend Growth

Abacus Life does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.78% of the float of Abacus Life has been sold short.

Short Interest Ratio / Days to Cover

Abacus Life has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Abacus Life has recently increased by 47.56%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.11

News Sentiment

Abacus Life has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for Abacus Life this week, compared to 5 articles on an average week.

Search Interest

4 people have searched for ABL on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Abacus Life to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Abacus Life insiders have not sold or bought any company stock.

Percentage Held by Insiders

47.00% of the stock of Abacus Life is held by insiders. A high percentage of insider ownership can be a sign of company health.

ABL Stock Analysis - Frequently Asked Questions

How have ABL shares performed this year?

Abacus Life's stock was trading at $7.83 at the start of the year. Since then, ABL shares have decreased by 31.9% and is now trading at $5.33.
View the best growth stocks for 2025 here.

How were Abacus Life's earnings last quarter?

Abacus Life, Inc. (NASDAQ:ABL) announced its quarterly earnings results on Thursday, May, 8th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.02. The firm had revenue of $44.14 million for the quarter, compared to analyst estimates of $39.51 million. Abacus Life had a positive trailing twelve-month return on equity of 16.76% and a negative net margin of 13.35%.
Read the conference call transcript.

How do I buy shares of Abacus Life?

Shares of ABL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Abacus Life own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Abacus Life investors own include Avino Silver & Gold Mines (ASM), Norwegian Cruise Line (NCLH), Construction Partners (ROAD), Wolverine World Wide (WWW), Broadcom (AVGO), Howard Hughes (HHH) and Lifeway Foods (LWAY).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: INS - LIFE
• Sub-Industry: Trading
• Current Symbol: NASDAQ:ABL
• CIK: 1814287
• Web: abacuslife.com
• Phone: 561-826-3620
• Fax: N/A
• Employees: 82
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $13.75
• High Stock Price Target: $16.00
• Low Stock Price Target: $10.00
• Potential Upside/Downside: +158.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 8.60
• P/E Growth: N/A
• Net Income: -$23.96 million
• Net Margins: -13.35%
• Pretax Margin: -8.62%
• Return on Equity: 16.76%
• Return on Assets: 8.52%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 0.47
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $111.92 million
• Price / Sales: 4.61
• Cash Flow: $0.59 per share
• Price / Cash Flow: 8.97
• Book Value: $4.38 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 96,850,000
• Free Float: 51,332,000
• Market Cap: $516.21 million
• Optionable: Optionable
• Beta: 0.01